News

DSC127 is a patented, topically applied novel angiotensin analog that targets receptors that are up-regulated following injury to tissue. The double-blind, placebo-controlled, multi-centre clinical trial enrolled 80 patients

Quercetin is a natural polyphenolic antioxidant flavonoid found in many plants, and plays an important role in the inhibition of enzymes involved in free radical production. It can

Hospira, which expects to launch the product by the end of February, said topotecan 4 mg/4 ml is designed to improve caregiver convenience and safety. Hospira US president

They have also signed a new co-promotion agreement for the investigational drug tofacitinib, formerly known as tasocitinib, which is being studied for multiple inflammatory conditions, including RA, in

Besides cGMP (current good manufacturing practices) manufacturing, Avecia Biotechnology ‘s services also include the development of analytical methods, process validation, stability studies, quality control, and regulatory support for

Pre-configured with the Torrent Suite Software, the scalable computing platform converts raw signal into base calls in less than an hour and delivers the data to the end

The Cancer Vaccine Acceleration Fund (CVAF) – a joint initiative between the Cancer Research Institute and the Ludwig Institute for Cancer Research – has completed a new investment

Almost $1.7bn charges before taxes were due to a setback for its experimental blood clot preventer vorapaxar. However, Merck beat forecasts on strong sales growth from its key

Pfizer CEO Ian Read announced slashing the drug maker’s research budget by a third to $6.5bn to $7bn over the next two years, bloomberg.com reported. Meanwhile, Merck CEO